05:00 PM EDT, 09/19/2024 (MT Newswires) -- Susanna Gatti High, Chief Operating Officer, on Sept. 18, sold 8,976 shares in Dyne Therapeutics ( DYN ) for $308,864. Following the Form 4 filing with the SEC, High has control over a total of 131,636 shares of the company, with 131,636 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1818794/000095017024108154/xslF345X05/ownership.xml